Concert Pharmaceuticals (CNCE) News Today → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free CNCE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNFL pushed networks to air Taylor Swift concert film promos — for freenypost.com - October 28 at 11:46 PMBeyoncé 'Renaissance' Movie Tickets and How To See Concert Film in Theatersmsn.com - October 2 at 2:21 PMTaylor Swift 'overjoyed' to release Eras Tour concert movie: How to watchusatoday.com - September 15 at 7:06 PMBruce Springsteen forced to postpone Philadelphia concerts with E Street Band due to illnessusatoday.com - September 12 at 10:17 PMMiranda Lambert scolds fans for taking selfies during her concert: 'I don't like it'usatoday.com - August 7 at 7:37 AMThe worst people at concerts, from self-involved selfie takers to nonstop filmersusatoday.com - August 6 at 4:42 AMHighlights from King Charles III Coronation concertbbc.co.uk - July 25 at 2:38 AMFan throws bag of ashes at Pink during tour concertusatoday.com - July 17 at 8:19 AMBirds Papaya stuns fans in Shania Twain-inspired outfit for concertca.style.yahoo.com - July 4 at 1:10 AMHow to watch the Coronation and Coronation Concert on BBC TV and iPlayer and listen on radio and BBC Soundsbbc.com - May 7 at 12:56 PMTicket ballot for the Coronation Concertbbc.co.uk - May 4 at 8:55 AMConcert Pharmaceuticals (NASDAQ:CNCE) Earns Sell Rating from Analysts at StockNews.commarketbeat.com - April 5 at 1:17 AMConcert Pharmaceuticals (NASDAQ:CNCE) Coverage Initiated at StockNews.commarketbeat.com - March 28 at 1:09 AMWho is Florence Price? Find out at a free Philadelphia Orchestra concert Saturdaymsn.com - March 26 at 9:32 AMAssenagon Asset Management S.A. Lowers Holdings in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)marketbeat.com - March 26 at 4:17 AMConcert Pharmaceuticals (NASDAQ:CNCE) Coverage Initiated by Analysts at StockNews.commarketbeat.com - March 20 at 1:14 AMRenaissance Technologies LLC Sells 285,579 Shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)marketbeat.com - March 13 at 4:43 AMmarketbeat.com - March 6 at 6:01 AMCantor Fitzgerald L. P. Takes Position in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)marketbeat.com - March 3 at 7:47 AMConcert Pharmaceuticals (NASDAQ:CNCE) Cut to "Sell" at StockNews.commarketbeat.com - February 25 at 12:16 AMConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areatafinance.yahoo.com - February 15 at 8:15 AMHarvest Investment Services LLC Makes New $282,000 Investment in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)marketbeat.com - February 8 at 12:19 PMAnalysts Are Neutral on These Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Concert Pharma (CNCE)markets.businessinsider.com - February 6 at 1:21 PMInternational Biotechnology Trust PLC Acquires 198,190 Shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)marketbeat.com - February 1 at 10:43 AMMoore Kuehn Encourages KERN, CNCE, AQUA and ANGN Investors to Contact Law Firmbenzinga.com - January 30 at 12:58 AMConcert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offerfinance.yahoo.com - January 23 at 3:55 PMConcert Pharmaceuticals, Inc. to Post FY2027 Earnings of $0.39 Per Share, Jefferies Financial Group Forecasts (NASDAQ:CNCE)marketbeat.com - January 23 at 2:01 AM5 big deal reports: Sun Pharma’s $576M pact for Concert Pharmamsn.com - January 22 at 6:24 PMStockNews.com Downgrades Concert Pharmaceuticals (NASDAQ:CNCE) to Sellmarketbeat.com - January 21 at 12:20 AMWhy Concert Pharmaceuticals Stock Rocketed Higher This Weekfinance.yahoo.com - January 20 at 6:28 PMCNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholdersmarketwatch.com - January 20 at 12:34 AMSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Concert Pharmaceuticals, Inc. (CNCE)benzinga.com - January 19 at 2:33 PMShareholder Alert: Ademi LLP investigates whether Concert Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Sun Pharmabenzinga.com - January 19 at 2:33 PMConcert Pharmaceuticals Shares Rally on Takeover by Sun >CNCEmarketwatch.com - January 19 at 2:33 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Concert Pharmaceuticals, Inc. Buyoutwsj.com - January 19 at 2:33 PMIndia-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestonesfinance.yahoo.com - January 19 at 2:33 PMPharma giant in India buys Concert Pharmaceuticals in $576M dealfinance.yahoo.com - January 19 at 2:33 PMSun Pharmaceutical to Buy Concert Pharmaceuticals For Initial $576 Million >CNCEmarketwatch.com - January 19 at 9:33 AMSun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areatafinance.yahoo.com - January 19 at 9:33 AMUPDATE 1-India's Sun Pharma to acquire U.S.-based Concert for $576 mlnfinance.yahoo.com - January 19 at 9:33 AMmarketbeat.com - January 19 at 7:58 AMConcert (CNCE) Moves 19.3% Higher: Will This Strength Last?finance.yahoo.com - January 9 at 12:22 PMWith 66% ownership in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), institutional investors have a lot riding on the businessfinance.yahoo.com - December 26 at 9:16 AMStockNews.com Upgrades Concert Pharmaceuticals (NASDAQ:CNCE) to Holdmarketbeat.com - December 10 at 12:09 AMBullish insiders bet US$1.1m on Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)finance.yahoo.com - December 5 at 5:39 PMConcert Pharmaceuticals's Return On Capital Employed Insightsmsn.com - November 29 at 3:41 PMIs Ardelyx is A Buy After Slip in Early 2022 (CNCE)marketbeat.com - November 21 at 1:45 PMConcert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Researchfinance.yahoo.com - November 21 at 7:41 AMShort Interest in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Expands By 12.8%marketbeat.com - November 15 at 8:53 PMFurther weakness as Concert Pharmaceuticals (NASDAQ:CNCE) drops 13% this week, taking five-year losses to 77%finance.yahoo.com - November 14 at 11:57 AM Get Concert Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details CNCE Media Mentions By Week CNCE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNCE News Sentiment▼0.400.60▲Average Medical News Sentiment CNCE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNCE Articles This Week▼00▲CNCE Articles Average Week Get Concert Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STTK News DNTH News AQST News EPIX News TERN News ADCT News ESPR News AKBA News MREO News LRMR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNCE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concert Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.